Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP262915.RAayHg9TuahAYvskhim_pGTSGDFZg8lj06GhC0TyrquIc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP262915.RAayHg9TuahAYvskhim_pGTSGDFZg8lj06GhC0TyrquIc130_assertion type Assertion NP262915.RAayHg9TuahAYvskhim_pGTSGDFZg8lj06GhC0TyrquIc130_head.
- NP262915.RAayHg9TuahAYvskhim_pGTSGDFZg8lj06GhC0TyrquIc130_assertion description "[We carried out a gene expression profiling study using cDNA array technology with 24 primary glioma tissues of low-grade (oligodendroglioma), intermediate-grade (anaplastic oligodendroglioma and anaplastic astrocytoma), and high-grade (glioblastomas multiforme) tumors and found that insulin-like growth factor binding protein 2 (IGFBP2) was consistently overexpressed only in glioblastoma multiforme.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP262915.RAayHg9TuahAYvskhim_pGTSGDFZg8lj06GhC0TyrquIc130_provenance.
- NP262915.RAayHg9TuahAYvskhim_pGTSGDFZg8lj06GhC0TyrquIc130_assertion evidence source_evidence_literature NP262915.RAayHg9TuahAYvskhim_pGTSGDFZg8lj06GhC0TyrquIc130_provenance.
- NP262915.RAayHg9TuahAYvskhim_pGTSGDFZg8lj06GhC0TyrquIc130_assertion SIO_000772 10485462 NP262915.RAayHg9TuahAYvskhim_pGTSGDFZg8lj06GhC0TyrquIc130_provenance.
- NP262915.RAayHg9TuahAYvskhim_pGTSGDFZg8lj06GhC0TyrquIc130_assertion wasDerivedFrom befree-2016 NP262915.RAayHg9TuahAYvskhim_pGTSGDFZg8lj06GhC0TyrquIc130_provenance.
- NP262915.RAayHg9TuahAYvskhim_pGTSGDFZg8lj06GhC0TyrquIc130_assertion wasGeneratedBy ECO_0000203 NP262915.RAayHg9TuahAYvskhim_pGTSGDFZg8lj06GhC0TyrquIc130_provenance.